Sacubitril/Valsartan is an angiotensin receptor neprilysin inhibitor (ARNI) that combines Valsartan, an established angiotensin receptor blocker with proven cardiac mortality and remodelling benefits in HF, with Sacubitril, a neprilysin (NEP) inhibitor providing additional protection [7, 12]. Here, MME is linked to hydrops fetalis.